Merck Healthcare - Latest News [Page 1]
First Targeted Therapy For Bowel Cancer Funded In New Zealand From Today: ERBITUX® (cetuximab)
Friday, 1 November 2024, 9:32 pm | Merck Healthcare
Managing Director of Merck Healthcare Australia and New Zealand, Josie Downey, says today’s listing of ERBITUX® - a targeted therapy that prevents the growth and further spread of cancer - is due to the hard work of many. More >>
Merck Welcomes Funded Access To Cancer Treatment Erbitux® (Cetuximab)
Wednesday, 16 October 2024, 9:59 pm | Merck Healthcare
Merck acknowledges that the news of ERBITUX® being publicly funded will be welcome in particular for the many who have waited so long. More >>